Sixty pre-IPO unicorns deferred an average $358 million of stock comp into their listing quarter

Sixty firms at an average of $358 million each is about $21.5 billion of compensation expense landing in 60 first quarterly reports ^[2][1]. Set the average against the sample's median pre-money valuation of $11.4 billion and it comes to roughly 3.1% of the private price ^[4][2]. On its own, that is a charge a stock can absorb. The line Riethmueller draws is at $107 million of deferred expense, and the average deferrer in his sample sits 3.3 times above it ^[6][3].

The figure is in the filing. Cryptobriefing's account of the paper says institutional investors with the resources to dig into S-1 filings can use deferred RSU expense as a screening tool, while retail investors typically work with less information and less time ^[10]. Grants happen before the listing, and the accounting lets the expense wait for the IPO quarter, so the margin in the roadshow is wider than the margin that prints ^[7][8]. Cryptobriefing describes the sequence that follows: the charge appears, operating margins crater, the stock drops, and retail investors who bought at or near the IPO price absorb the loss ^[9]. The write-up does not report share counts or dilution ^[7].

Two other readings of the 83% get there without insider design. Deferral size may track price, and at least 30 of these companies held post-money valuations of $11 billion or more ^[5]. Thirty-one of the 91 sit outside the deferring group ^[4]. If those 31 declined at a similar rate after their own first print, the footnote tells a buyer only how big the charge is. Cryptobriefing's write-up also calls the 83% a probability in one paragraph and a correlation in another ^[6][14].

Riethmueller's 2024 options work points the same way from the other end. A strike set 48% below the eventual offer price is 52% of it, a 92% gain at the offer before the shares trade anywhere ^[11][5]. He put the average potential windfall at $4.2 million per firm ^[13].

In my view the usable part is narrow. For any listing whose S-1 footnotes show a deferred RSU charge near or above $107 million, the first public earnings report, not the offer, is where the margin gets set ^[6]. Waiting one quarter costs a buyer the 17% of cases in the sample where the stock did not decline ^[6]. What would break the thesis is a control group: publish the post-print returns of the 31 non-deferrers, and if they fall at anything like 83%, the screen is measuring how 2014 to 2024 listings seasoned and the footnote only sizes the charge ^[4].